problems in urinary stents
exchange of knowledge
design and materials
quality of life
European Network of multidisciplinary research to Improve the Urinary Stents (ENIUS) is a network supported by COST. The indwelling of the urinary stents represents a very frequently used method within the urological practice, in order to ensure the drainage of the urine. Regardless of its composition, polymeric or metallic, it is associated with a high morbidity.
Success in this Action will contribute to improved healthy-quality of patients, reduction in health care costs, and increase the competitiveness of the European medical device industry. Our prime objective is to create a multidisciplinary group to identify the inherent problems in urinary stents and propose improvements for future urinary stents.
March, 2019
ENIUS organized under the leadership of Dr. A. Barros-Portugal (WG4-Leader) and Prof. G. Ciardelli (WG5-Leader) a magnificent Workshop focused on Biomaterials, drug delivery systems and coatings applied to urinary stents. This Workshop was attended by 36 attendees.
March, 2019
January, 31st. and 1st February, 2019. About 30 MC members from 20 countries joined in the 2nd ENIUS Management Committe Meeting in Sofia-Bulgaria (CA16217).
December, 2018
Twenty trainees from Poland, Portugal, France, Finland, Holland, Spain, France, USA, Macedonia, Ireland and UK, attended the Training School organised by ENIUS network (CA16217) COST Actions.
WG1
This WG will focus its work in analysing the current literature on ureteral, urethral and prostatic stents from a multidisciplinary point of view.
Read MoreWG2
The WG2 focuses its work in developing a computational setting to assess future stent designs, a world novelty.
Read MoreWG3
The WG3 will be in charge of developing the Methodology and validation protocols of future urinary tract stents.
Read MoreWG4
The WG4 will work on the search of new biomaterials-nanomaterials and coatings with improved behaviour at urinary tract level.
Read MoreWG5
Following the idea of incorporating drugs onto the stent surface, several substances have already been used in DESs.
Read MoreWG6
Coating of the stent surface is a developing field with significant potential for the reduction of stent-related complications.
Read More